Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction
Disease Markers · 03.10.2022 · 2022 · 1-12
DOI: 10.1155/2022/9311684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Markers, erschienen am 03.10.2022. Verfasst von Rui-Jie Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Jinan Central Hospital, Shandong University, Jinan 250013, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adenocarcinoma of the esophagogastric junction (AEG) has increased rapidly worldwide during the last few decades. The purpose of this study is to investigate the clinical and prognostic characteristics of signal transduction and activator of transcription factor 3(STAT3) and phosphorylated STAT3 (p-STAT3) expression in AEG patients. We retrospectively analyzed the immunohistochemical results of 61 AEG patients and followed up for 5 years, while Western blot was performed on tissues from another 30 AEG patients. The results showed that STAT3 and p-STAT3 were overexpressed in AEG tissues ( P < 0.05 , P < 0.01 ). The high expression of STAT3 was significantly associated with the pTNM stage ( P < 0.05 ), and the increased expression of p-STAT3 was significantly associated with depth of invasion (pT), lymph node metastasis (pN), and pTNM stage ( P < 0.05 , P < 0.05 , P < 0.05 ). The 5-year survival rate for AEG patients was 41.0% and was significantly associated with tumor differentiation, pN, pTNM, and p-STAT3 ( P < 0.05 , P < 0.01 , P < 0.05 , P < 0.01 ). Cox regression analysis confirmed that tumor differentiation, pN, and high expression of p-STAT3 were independent risk factors for the 5-year survival rate in patients with AEG ( P < 0.05 , P < 0.01 , P < 0.05 ). Our study showed that STAT3 and p-STAT3 play a critical role in AEG development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Jinan Central Hospital, Shandong University, Jinan 250013, China.
- Department of Breast Disease Center, Jinan Central Hospital, Shandong University, Jinan 250013, China.
- Department of Thoracic Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan 250013, China.
ORCID-Profile: Rui-Jie Ma, Qi-Ming Zheng, Nan Zhang, Zhi-Gang Sun
Zitieren
APA
Ma, R. J., Zheng, Q. M., Zhang, N., & Sun, Z. G. (2022). Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction. Disease Markers, 2022, 1-12. https://doi.org/10.1155/2022/9311684
Vancouver
Ma RJ, Zheng QM, Zhang N, Sun ZG. Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction. Disease Markers. 2022;2022:1-12. doi:10.1155/2022/9311684
BibTeX
@article{Ma2022,
author = {Ma, Rui-Jie and Zheng, Qi-Ming and Zhang, Nan and Sun, Zhi-Gang},
title = {Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction},
journal = {Disease Markers},
year = {2022},
volume = {2022},
pages = {1--12},
doi = {10.1155/2022/9311684}
}
EUVIMED